Antimicrobial peptides derived from microalgae for combating antibiotic resistance: Current status and prospects.

Microalgae are photosynthetic cell factories that produce a spectrum of bioactive compounds extensively used for various applications. Owing to the increase in antibiotic resistance among microbial pathogens, there is a significant thrust for identifying new treatment strategies, and antimicrobial peptides (AMPs) generation is one such method. These AMPs have multiple roles and are active against bacteria, fungi, and viruses. Such peptides synthesized in microalgae have a significant role in medical application, managing aquaculture‐associated diseases, and the food industry. To increase their effectiveness and novel peptides, genetically modified microalgae are used as cell factories. With the advancement of new technologies like the CRISPR‐Cas system, new avenues are opened for developing novel AMPs using microalgae. This review gives us insight into the various AMPs produced by microalgae and multiple technologies involved in creating such therapeutically essential molecules. Significance statement: Antimicrobial peptides (AMPs) are widely studied. However, this present manuscript mainly focuses on AMPs from microalgae. This also tries to shed light on the research gaps and the major challenges in microalgae‐derived AMPs. The technological advancements in AMPs production and its progress also have been addressed. [ABSTRACT FROM AUTHOR]